2025-02-14 11:00:25 ET
Summary
- AbbVie Inc. offers a combination of rock-solid business mix, aggressive growth strategy, and shareholder-friendly capital allocation.
- The company holds strong positions in rapidly growing markets like immunology, neuroscience, and aesthetics, ensuring resilience and a wide moat.
- AbbVie consistently increases dividends, supported by solid financial health, robust cash reserves, and moderate leverage, reinforcing its attractiveness to investors.
- Despite intense competition and potential regulatory uncertainties, ABBV stock's intrinsic value calculation shows a 15% upside, further supporting the bullish outlook.
My thesis
Read the full article on Seeking Alpha
For further details see:
AbbVie: An Undervalued Dividend Aristocrat